Full Text
PCN4 RETROSPECTIVE COST ANALYSIS OF GEMZARTM IN COMBINATION WITH CISPLATIN IN NON-SMALL CELL LUNG CANCER COMPARED TO OTHER COMBINATION THERAPIES IN GERMANY

Abstract

Authors

A Kielhorn N Maniadakis M Aristides M Lees D Tilden

Back to Volume 5, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×